The healthcare sector has historically been a resilient place for investors to park cash. The companies that operate in this space often provide life-saving medicines, devices, and solutions that consumers need regardless of what is happening with the domestic or global economy. That fact can make healthcare businesses a wise addition to a well-diversified investment portfolio in a wide range of market environments.

If you're looking for healthcare stocks trading at particularly attractive valuations right now, here are two names to consider for your buy list.

's (NYSE: ABBV) growth has slowed since it lost patent exclusivity for Humira last year. However, the company positioned itself well to recover from the financial impact it knew this change would bring. While AbbVie will likely continue to face a transition period over the next few quarters as the impact of waning Humira sales plays out, it has other blockbuster drugs in its portfolio as well as a promising pipeline that long-term investors would do well to factor into their buying decision.

Continue reading

Source Fool.com